相关实验视频

Updated: May 24, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

MIF-ACKR3通过损害癌症缓解症中的脂肪生成而导致不可逆转的脂肪损失

Qionghua Cui¹, Shijin Li¹, Xidan Liu¹

¹State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing 100871, China.

Cell metabolism

|February 28, 2025

概括

瘤分泌的巨细胞迁移抑制因子 (MIF) 通过促进脂肪组织炎症和纤维化来驱动癌症缓解症. 针对MIF-ACKR3信号通路为这种情况提供了潜在的治疗策略.

科学领域:

分子生物学分子生物学
在瘤学瘤学.
代谢疾病代谢疾病

背景情况:

脂肪组织收缩发生在运动和癌症中.
癌症缓解症是不同的,由脂肪组织炎症和纤维化标志着.
驱动癌症缓解症相关的脂肪组织变化的潜在机制尚未完全理解.

研究的目的:

为了确定脂肪组织功能障碍的关键分子驱动因素在癌症缓解症.
阐明巨细胞迁移抑制因子 (MIF) 在癌症缓存症中的作用.
调查针对MIF-ACKR3信号的治疗潜力.

主要方法:

研究了瘤分泌的巨细胞迁移抑制因子 (MIF) 的作用.
检查了脂肪干细胞和原生细胞 (ASPC) 的分化.
在瘤细胞中利用基因切除和MIF的药理阻断.
评估了ASPC特定的Ackr3缺陷的影响.

主要成果:

瘤分泌的MIF促进ASPCs的亲炎和亲纤维素分化,降低脂肪生成能力.
运动后循环MIF水平适度降低,与癌症缓解症形成鲜明对比.
在ASPC上的非典型化学因子受体3 (ACKR3) 是MIF病理效应的主要受体.
抑制MIF或ACKR3可显著缓解瘤诱导的缓解症.

结论:

来自瘤的MIF是癌症缓解症的关键调解者.
MIF-ACKR3信号轴代表了瘤和缓解症状之间的关键联系.
准MIF-ACKR3信号传递是一个有希望的治疗途径,用于管理癌症缓解症.

关键词:

在ACKR3中,它是ACKR3.多元期权基金和多元期权基金.脂肪重塑的重塑脂肪重塑脂肪干细胞和原始细胞.癌症缓冲症癌症缓冲症

更多相关视频

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

Adipocyte-Specific ATAC-Seq with Adipose Tissues Using Fluorescence-Activated Nucleus Sorting

Adipocyte-Specific ATAC-Seq with Adipose Tissues Using Fluorescence-Activated Nucleus Sorting

Published on: March 17, 2023

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...